Professional profile
About Tian
Partner | Capital markets, M&A, private funds, securities disputes
Tian Duoyu is a partner in Jingshi Law Offices’ Hefei office whose practice focuses on domestic IPOs, mergers and acquisitions, private investment funds and securities-related disputes. His official profile identifies experience advising on multiple STAR Market listings, corporate restructurings, financings and private-fund matters. His representative projects include legal services for the STAR Market listings of Anhui Estone Materials Technology, Anhui Yuanchen Environmental Protection Science and Technology, and Hefei Circuit Fabology Microelectronics Equipment, as well as securities financing transactions for listed companies.
Read full profile
This profile is closely aligned with Hefei’s technology and advanced-manufacturing economy. Many local companies move through several stages of institutional capital before listing: venture financing, strategic investment, acquisitions, employee incentives, restructuring and finally IPO preparation. Legal work at each stage can create issues that later affect listing independence, related-party relationships, capitalization and disclosure.
Tian’s experience on STAR Market projects is particularly relevant because technology issuers need to show not only legal compliance but also a coherent ownership, governance and business story. An acquisition completed shortly before an IPO can attract scrutiny if it materially changes the issuer’s revenue, technology, customer concentration, related-party relationships or historical financial comparability. The transaction may be commercially attractive but still complicate the listing timetable.
His M&A practice gives him the transaction-side tools needed to address those questions before the acquisition is signed. A pre-IPO company should not evaluate a target only on valuation and synergies. It should ask whether the acquisition changes the issuer’s principal business, whether the target depends on related parties, whether goodwill becomes material, whether the combined company has stable internal controls and whether the purchase price can be supported by evidence.
Tian’s private-fund experience adds an investor perspective. Venture and private-equity investors often encourage portfolio companies to acquire complementary technology or customer relationships before listing. Yet investors also depend on a timely IPO exit. The legal team must therefore balance acquisition value against the possibility that a late transaction delays or complicates the listing.
His securities-dispute practice is relevant because disclosure failures can create post-listing liability. Transaction documents, valuation work and board approvals should be prepared with future disclosure in mind. If management describes the acquisition one way to investors, another way in the prospectus and a third way in accounting documents, the inconsistency can become a regulatory and litigation problem.
Tian’s experience advising listed and pre-listing companies also suggests familiarity with corporate governance and financing. A pre-IPO acquisition may require new debt, share issuance, related-party approvals or adjustments to employee equity plans. Those decisions can affect the issuer’s capital structure and the information that intermediaries need to verify.
For a company already preparing for an IPO, M&A timing becomes a governance issue as well as a strategic issue. The board should understand how the acquisition affects the issuer’s historical financial information, internal controls, related-party relationships and disclosure timetable. A transaction that would be routine for a private company can become disproportionately disruptive if completed immediately before filing.
Tian’s private-fund practice is useful in that context because many acquisitions are encouraged or financed by existing institutional investors. Those investors may focus on revenue growth or technology synergies, while the sponsor and securities lawyers focus on listing stability. Counsel needs to reconcile those objectives and explain when a transaction should close before filing, be deferred until after listing, or be structured as a minority investment.
His experience in securities disputes also adds a preventive dimension. If the acquisition later performs poorly, investors may scrutinize the valuation, board decision and prospectus disclosure. The company should therefore preserve the commercial rationale, independent valuation work, conflict checks and integration assumptions at the time of the deal. Good pre-IPO M&A documentation is designed not only to obtain approval but to withstand later review.
Tian’s representative STAR Market work also gives him familiarity with the verification burden placed on securities intermediaries. A pre-IPO transaction should be structured so that the sponsor, accountants and lawyers can reconstruct why the company completed it, how the price was determined, what relationships existed with the counterparty and how the acquisition was integrated. If those answers depend on undocumented management explanations, the acquisition can become a disclosure problem.
That verification perspective is particularly useful for technology issuers making acquisitions close to a planned filing.
Tian’s experience with several Hefei and Anhui technology issuers is also relevant to acquisition timing because listing preparation requires a stable factual record. A transaction completed close to filing should be capable of being verified through board materials, valuation evidence, ownership records and integration documentation. That discipline helps the issuer avoid explaining material acquisition decisions through hindsight after the sponsor and regulators begin asking detailed questions.
His experience also gives him relevance to management teams deciding whether a strategic transaction belongs before or after the listing process. The legal question is not simply whether an acquisition is permissible, but whether it can be verified, integrated and disclosed without undermining the issuer’s timetable. That sequencing judgment is a recurring issue for fast-growing technology companies approaching the public markets.
Capability
